Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 37.7 Cr.
- Current Price ₹ 15.2
- High / Low ₹ 32.9 / 14.5
- Stock P/E 26.8
- Book Value ₹ 44.0
- Dividend Yield 0.00 %
- ROCE 1.69 %
- ROE 1.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.35 times its book value
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 18.4%
- Company has a low return on equity of 1.15% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
- Promoter holding has decreased over last 3 years: -3.79%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.26 | 39.52 | 16.16 | 29.34 | 37.83 | 44.25 | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.13 | 87.12 | |
| 28.28 | 38.54 | 9.81 | 16.54 | 23.77 | 27.44 | 30.57 | 31.74 | 27.54 | 42.97 | 55.97 | 71.95 | 83.46 | |
| Operating Profit | 0.98 | 0.98 | 6.35 | 12.80 | 14.06 | 16.81 | 11.67 | 2.04 | 5.63 | 2.05 | 3.76 | 3.18 | 3.66 |
| OPM % | 3.35% | 2.48% | 39.29% | 43.63% | 37.17% | 37.99% | 27.63% | 6.04% | 16.97% | 4.55% | 6.29% | 4.23% | 4.20% |
| 0.09 | 0.09 | -0.17 | 0.05 | 2.07 | 0.08 | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Interest | 0.01 | 0.10 | 1.48 | 2.14 | 1.50 | 1.04 | 0.18 | 0.11 | 0.15 | 0.11 | 0.06 | 0.07 | 0.22 |
| Depreciation | 0.02 | 0.22 | 1.15 | 1.19 | 1.28 | 1.29 | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.47 |
| Profit before tax | 1.04 | 0.75 | 3.55 | 9.52 | 13.35 | 14.56 | 10.13 | 0.52 | 0.55 | 0.53 | 2.24 | 1.67 | 1.98 |
| Tax % | 17.31% | 30.67% | 0.28% | -0.21% | -0.15% | 0.62% | 0.39% | 25.00% | 40.00% | 26.42% | 32.59% | 28.14% | |
| 0.86 | 0.53 | 3.54 | 9.54 | 13.36 | 14.48 | 10.09 | 0.39 | 0.32 | 0.40 | 1.52 | 1.20 | 1.41 | |
| EPS in Rs | 1.61 | 0.99 | 3.39 | 7.38 | 9.90 | 9.22 | 6.42 | 0.25 | 0.20 | 0.23 | 0.75 | 0.51 | 0.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 31% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -35% |
| 3 Years: | -20% |
| TTM: | -11% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -14% |
| 3 Years: | -28% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.33 | 5.33 | 10.43 | 12.93 | 13.50 | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves | 1.24 | 11.08 | -2.03 | 9.21 | 32.68 | 50.43 | 60.52 | 60.91 | 61.23 | 64.61 | 76.66 | 83.13 | 84.21 |
| 0.00 | 10.46 | 13.94 | 10.94 | 10.90 | 1.41 | 1.30 | 1.03 | 1.25 | 1.55 | 1.41 | 1.15 | 1.33 | |
| 3.02 | 3.29 | 7.00 | 16.51 | 13.40 | 15.30 | 15.46 | 14.61 | 12.44 | 13.28 | 8.87 | 16.22 | 25.90 | |
| Total Liabilities | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
| 0.08 | 18.54 | 17.12 | 17.32 | 17.71 | 20.85 | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 13.69 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.51 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| 9.51 | 11.62 | 12.22 | 32.25 | 49.26 | 62.00 | 71.74 | 72.31 | 72.09 | 79.62 | 91.62 | 109.54 | 122.49 | |
| Total Assets | 9.59 | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 136.19 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 3.04 | 2.28 | 12.92 | 2.62 | 2.68 | 0.22 | -0.57 | -6.59 | -12.48 | -6.60 | |
| 0.00 | 0.00 | 0.00 | -1.40 | -12.90 | -11.53 | -1.94 | -0.08 | -0.05 | 0.26 | -0.30 | -0.14 | |
| 0.00 | 0.00 | -2.91 | -0.95 | 0.21 | 13.07 | -1.77 | -0.37 | 0.07 | 5.06 | 13.64 | 8.01 | |
| Net Cash Flow | 0.00 | 0.00 | 0.13 | -0.08 | 0.23 | 4.16 | -1.03 | -0.23 | -0.55 | -1.27 | 0.86 | 1.27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52.39 | 50.24 | 181.82 | 229.90 | 170.49 | 159.86 | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 61.26 |
| Inventory Days | 48.33 | 34.08 | 269.62 | 432.36 | 596.97 | 773.64 | 825.88 | 890.81 | 1,182.75 | 683.64 | 445.05 | 326.33 |
| Days Payable | 42.96 | 31.06 | 264.36 | 447.94 | 173.22 | 185.88 | 153.84 | 112.09 | 146.00 | 123.28 | 41.39 | 68.52 |
| Cash Conversion Cycle | 57.76 | 53.25 | 187.08 | 214.32 | 594.24 | 747.62 | 849.70 | 913.46 | 1,177.82 | 657.58 | 464.10 | 319.07 |
| Working Capital Days | 55.51 | 51.72 | -155.17 | 193.82 | 240.82 | 321.94 | 421.77 | 545.99 | 603.01 | 502.26 | 477.19 | 423.69 |
| ROCE % | 5.08% | 42.08% | 32.94% | 25.03% | 14.21% | 0.81% | 5.62% | 0.79% | 2.53% | 1.69% |
Documents
Announcements
-
Disclosure under Regulation 30A of LODR
1d - Ronak Darji resigned as Company Secretary & Compliance Officer effective close of business on 01 Dec 2025.
-
Disclosure under Regulation 30A of LODR
2d - Ronak Darji resigned as Company Secretary & Compliance Officer effective COB 01-Dec-2025; Mohita Gupta named compliance officer.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - News Paper Publication for Unaudited Financial Results for Quarter ended September 2025
-
Announcement under Regulation 30 (LODR)-Investor Presentation
14 Nov - Investor Presentation for Financial Results for Quarter ended Sep 2025
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14 Nov - Q2 FY2025-26 standalone revenue ₹2,440.46 lakh (+29.7% YoY); Q PAT ₹89.97 lakh; launches March 2026.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com